The APOE4 Glucose–Lactate Homeostasis Hypothesis of Alzheimer's Disease: Substrate Mismatch, Proton–Redox Overload, and Impaired Clearance
The APOE4 allele is the strongest genetic risk factor for late-onset Alzheimer's disease, yet it represents an evolutionarily conserved human variant optimised for lipid transport, glucose conservation, and oxidative fatty-acid/ketone-body metabolism. Here, we propose that APOE4-associated neurodegeneration stems not from an inherent genetic defect, but from an evolutionary substrate-handling mismatch between ancestral metabolic capacity and chronic high-glycaemic substrate exposure. In APOE4 astrocytes, sustained supraphysiological D-glucose flux increases pyruvate conversion to lactate. Because monocarboxylate transporters (MCT1, MCT2, and MCT4) co-transport lactate with hydrogen ions (H+) in a 1:1 stoichiometry, continuous glycolytic overflow saturates transmembrane gradients, induces end-product inhibition, and shifts the cytosolic NAD+/NADH redox ratio—allosterically suppressing mitochondrial fatty-acid beta-oxidation. The resulting proton load diverts cellular ATP towards acid–base buffering and disrupts endosomal pH regulation via sodium–hydrogen exchanger 6 (NHE6), impairing low-density lipoprotein receptor-related protein 1 (LRP1) recycling and extracellular amyloid-beta clearance. Concurrently, elevated baseline extracellular lactate flattens the sharp concentration gradients required for activity-dependent astrocyte–neuron memory signalling, while osmotic and proton stress drive early astrocytic myo-inositol accumulation. As amyloid deposits form, they sequester endogenous brain lithium, disinhibiting glycogen synthase kinase-3 beta (GSK3β) and accelerating tau hyperphosphorylation. Key Contributions & Scope (Version 3.1):• Evolutionary Substrate-Mismatch Framework: Reframes APOE4 from an intrinsic genetic pathology to a lipid-conserving metabolic architecture overloaded by chronic postprandial D-glucose flux.• Mechanistic Cascade: Connects MCT1/2/4 proton–lactate co-transport and cytosolic NAD+/NADH redox shifts to NHE6/LRP1 endosomal clearance failure, early myo-inositol osmoregulation, and amyloid-mediated cortical lithium sequestration.• Falsifiable Experimental Protocol: Outlines a decisive, controlled test using human iPSC-derived isogenic APOE4 astrocyte–neuron co-cultures under clamped metabolic substrates, alongside explicit criteria that would refute the model.
Authors
- Theresa Gate (ORCID: https://orcid.org/0009-0002-4886-7925)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24328986
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- preprint